4-butyrolactone has been researched along with lovastatin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coffman, AD; Parsons, SJ; Schimmel, TG | 1 |
| Bizukojc, M; Boruta, T | 1 |
| Choi, MS; Kim, IS; Luo, Z; Rehman, SU; Xue, Y; Yao, G; Yoo, HH; Zhang, Y | 1 |
| Deng, M; Qi, C; Qiao, Y; Shi, Z; Sun, W; Tao, L; Xie, S; Zhang, Y | 1 |
4 other study(ies) available for 4-butyrolactone and lovastatin
| Article | Year |
|---|---|
Effect of butyrolactone I on the producing fungus, Aspergillus terreus.
Topics: 4-Butyrolactone; Aspergillus; Kinetics; Lovastatin; Spores, Fungal; Time Factors | 1998 |
Induction of secondary metabolism of Aspergillus terreus ATCC 20542 in the batch bioreactor cultures.
Topics: 4-Butyrolactone; Anthraquinones; Aspergillus; Batch Cell Culture Techniques; Benzofurans; Biomass; Bioreactors; Chromatography, High Pressure Liquid; Cyclopentanes; Fatty Acids, Monounsaturated; Fermentation; Inulin; Lovastatin; Phenyl Ethers; Pyridones; Rapeseed Oil; Secondary Metabolism | 2016 |
In Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate.
Topics: 4-Butyrolactone; Amlodipine; Chromatography, Liquid; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hypolipidemic Agents; Inactivation, Metabolic; Lovastatin; Microsomes, Liver; Monosaccharides; Substrate Specificity; Tandem Mass Spectrometry | 2016 |
New cytotoxic secondary metabolites against human pancreatic cancer cells from the Hypericum perforatum endophytic fungus Aspergillus terreus.
Topics: 4-Butyrolactone; Antineoplastic Agents; Aspergillus; Cell Line, Tumor; China; Flowers; Humans; Hypericum; Lovastatin; Pancreatic Neoplasms | 2020 |